The HMI cluster was characterized by genes involved in various classical tumor signaling pathways and immune processes, including PI3K-AKT, NF-κB, and IL-17 signaling pathways, and showed a low response rate to immunotherapy, possibly related to TAM2 enrichment. Here, PIK3CA is linked to neoplasm.